August 5, 2021 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced that Christopher Reidy, EVP, CFO, and chief administrative officer (CAO), has informed the company of his intent to retire.
Reidy joined BD as CFO in 2013 and has led numerous functions, including Finance, Business Development, IT and Global Shared Services.
He will serve in his current role until a successor, who is expected to be an external candidate, is in place, and he will assist the new CFO in the transition as well as continue to play an important leadership role in the spinoff of the Diabetes Care business unit.
The company is finalizing a plan that will include specific transition responsibilities and timing and says it will share details at a later date.
BD also announced that Reidy will become a director of the company formed in connection with the previously announced separation of the Diabetes Care business into an independent, publicly traded company (“NewCo”). His appointment to the board will be effective upon the completion of the spinoff, which is expected to occur in the first half of calendar 2022, subject to the satisfaction of customary conditions.